A lot to say about AZ vaccine pause in Europe, but I will try to stick to a two key questions in this thread (more later):
1. What are the symptoms that have led to the pause?
2. Is there a plausible mechanism for the vaccine causing them?

Story is here: sciencemag.org/news/2021/03/i…
1. There has been a lot of general talk about blood clots and deep vein thrombosis, but the picture described to @GretchenVogel1 and me by doctors and regulatory agencies is a much more complicated one and based on at least 13 previously healthy individuals from 5 countries.
@GretchenVogel1 Main characteristics seem to be:
- widespread blood clots
- few platelets (thrombocytopenia)
- internal bleeding
- cerebral venous thrombosis

As @steinarma told us: “It’s a very special picture”.
@GretchenVogel1 @steinarma In Germany, at least 7 cases of cerebral venous thrombosis within 4-16 days after vaccination have been reported (and I talked to a doctor treating another such case, which brings it to eight).
@PEI_Germany has stated that it would normally have expected just 1 case.
@GretchenVogel1 @steinarma @PEI_Germany That was enough for @PEI_Germany to bring in an outside group of experts on Monday and they “agreed unanimously that there seemed to be a pattern here and that a link to the vaccine was not implausible and that this should be investigated,” PEI head Klaus Cichutek told me.
@GretchenVogel1 @steinarma @PEI_Germany Now, to be very clear:
We do not know whether this is caused by the vaccine.
Rare medical events happen every day and when you vaccinate a lot, some of them will happen to people who were vaccinated.
And sometimes several rare events happen together, just by chance.
@GretchenVogel1 @steinarma @PEI_Germany But one reasonable question to ask is the second I want to concentrate on:
Is there any plausible mechanism by which a #covid19 vaccine could even cause something like this?
What has become clearer to me through our reporting is that this is not all that implausible.
@GretchenVogel1 @steinarma @PEI_Germany We know that #covid19 leads to clotting disorders in some people.
And this paper showed that #sarscov2’s spike protein can activate an arm of the immune system called the complement system, which then damages blood vessels and leads to clotting: ashpublications.org/blood/article/…
@GretchenVogel1 @steinarma @PEI_Germany What happens?
The virus binds to heparan sulfate on the surface of cells lining blood vessels. That might interfere with a molecule in the complement cascade, Factor H. That then leads to an activation of the complement system, which attacks the blood vessels.
@GretchenVogel1 @steinarma @PEI_Germany (Just realised I made a really stupid mistake, suggesting the AZ vaccine carries the spike on its surface, which, of course, it doesn’t. It just carries the gene for it into the cells it infects.
@nytimes has a nice explanation here for instance: nytimes.com/interactive/20…)
@GretchenVogel1 @steinarma @PEI_Germany @nytimes I probably just shouldn’t tweet this late…
But back to the thread. The question is: Could the AZ vaccine somehow trigger that same or a similar cascade, either through the spike protein whose recipe it carries or even the adenovirus vector itself if it reaches blood vessels?
@GretchenVogel1 @steinarma @PEI_Germany @nytimes One interesting aside here: Some people seem to be particularly prone to this type of complement dysregulation. So you could imagine that they might then be particularly at risk for this kind of reaction to the vaccine, but that they would also be at high risk of severe #covid19.
@GretchenVogel1 @steinarma @PEI_Germany @nytimes Anyway, all of this just to show that some fairly specific symptoms have been observed and that you can kind of see how a link to a #covid19 vaccine is not implausible. All of which makes me understand why the people making the decisions here have taken this so seriously.
@GretchenVogel1 @steinarma @PEI_Germany @nytimes I think the communication has been abysmal (I would have liked to have all this information days ago and publicly available and clearly explained.)
But there is a signal here that warrants investigation.
Was it right to pause vaccinations in the meantime? Debate for another day.
@GretchenVogel1 @steinarma @PEI_Germany @nytimes Most likely scenario to me still seems that we will restart vaccinations with AZ soon, maybe with an extra eye on certain symptoms that could signal a rare side effect.
At this moment in countries like Germany the cost of not vaccinating hundreds of thousands of people is huge.
@GretchenVogel1 @steinarma @PEI_Germany @nytimes Anyway, I hope the article clearly lays out what we know and what we don‘t know.
And thanks to my awesome colleague @GretchenVogel1 and my amazing editor @martinenserink
sciencemag.org/news/2021/03/i…

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Kai Kupferschmidt

Kai Kupferschmidt Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @kakape

18 Mar
"The committee has come to a clear scientific conclusion: This is a safe and effective vaccine. Its benefits in protecting people from #COVID19 with the associated risks of death and hospitalization outweigh the possible risks”, says Emer Cooke at @EMA_News press conference.
@EMA_News "The committee also concluded that the vaccine is not associated with an increase in the overall risk of thrombo embolic events or blood clots”, says Cooke.
@EMA_News "During the investigation and review we began to see a small number of cases of rare and unusual but very serious clotting disorders, and this then triggered a more focused review based on the evidence available”, says Cooke.
Read 17 tweets
18 Mar
EMA press conference on AstraZeneca safety signal is scheduled for 16.00 for now.

Just to give you an idea of what I will be looking out for, here are a few questions I would love to have answers to (and I don’t expect we can answer all of them already):
- Is there a significantly elevated number of people with the described clinical picture (widespread blood clotting, low platelet count, cerebral venous thrombosis) amongst vaccinees?
- Are there other things that unite them?
- Is there a common diagnosis? HUS, DIC, something?
- Is the age and gender distribution amongst cases unusual or in line with who was given the vaccine?
- Are most or all of the cases linked to a specific manufacturing plant?
- Any data on what treatments may have worked or not worked in these patients?
Read 4 tweets
16 Mar
Getting a TON of questions about AZ vaccine safety, so a few points as you watch news unfold the next days:
- There are no clear answers yet. Getting them will take time.
- There is a lot of bad info and speculation out there. Think long and hard about what sources you trust.
- Information flow takes time. So some dissonance now between different assessments may disappear when all have the same data on which to base their assessments. For now data from national authorities like that provided by PEI is most likely to be up-to-date.
- People are making extremely difficult decisions with a lot of uncertainty between two risky/bad outcomes.
If you think it is obvious what has to be done, at least consider that maybe you do not have all the information. Or maybe you have not thought all that hard about it.
Read 4 tweets
16 Mar
“I'm not here to give you the outcome of any scientific review”, says EMA director Emer Cooke at start of press conference on AstraZeneca vaccine safety. "I'm here to explain the steps in the process, what we're doing, and when you can expect us to come to a conclusion."
“This is not unexpected”, says Emer Cooke. “When you vaccinate millions of people, it's inevitable that you have rare or serious incidences of illnesses that occur after vaccination”. Role of EMA is to evaluate whether there is a causal effect or it is coincidence, she says.
Experts will meet Thursday "to come to a conclusion on the full information that has been gathered and to advise us as to whether there are any further actions that need to be taken”, says Cooke. “We will inform the public of the outcome immediately after this meeting."
Read 15 tweets
15 Mar
“More countries have suspended the use of AstraZeneca vaccines as a precautionary measure, after reports of blood clots in people who had received the vaccine from two batches produced in Europe”, says @DrTedros at @WHO presser on #covid19.
@DrTedros @WHO "This does not necessarily mean these events are linked to vaccination”, says @drtedros. "WHO’s Advisory Committee on Vaccine Safety has been reviewing the available data, is in close contact with the @EMA_News and will meet tomorrow."
@DrTedros @WHO @EMA_News “But the greatest threat that most countries face now is lack of access to #COVID19 vaccines”, says @drtedros. "Almost every day, I receive calls from senior political leaders around the world, asking when their country will receive their vaccines through COVAX."
Read 9 tweets
13 Mar
We can all use some good news, so let’s talk about influenza season here in Germany for a second.

@rki_de publishes a weekly summary of the situation (current one: influenza.rki.de/Wochenberichte…)

Lab-confirmed infections this time last year: 119,820
This year: 449

You read that right Image
@rki_de There is also a sentinel program in which doctors send in samples from patients with respiratory disease symptoms to the national reference laboratory.

Number of samples with influenza viruses this time last year: >600
This year: 0 ImageImage
@rki_de The situation in Germany mirrors that in countries across the world. Here is the excellent @HelenBranswell with the view from the US:
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!